drugset / Trial / NCT00577304

A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon

NCT00577304

Phase 3 Unknown 200 enrolled MediQuest Therapeutics
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this research study is to test the safety, tolerability, and effectiveness of Topical AmphiMatrix with Nitroglycerin (MQX0503) to relieve Raynaud's symptoms and increase blood flow to the fingers.

Timeline

Start
2007-12
Primary completion
2008-03
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nitroglycerin Unknown 4.5 mg Topical